Hanin Leonid G, Miller Anthony, Zorin A V, Yakovlev Andrei Y
Department of Mathematics, Idaho State University, Pocatello, ID, USA.
J Natl Cancer Inst Monogr. 2006(36):66-78. doi: 10.1093/jncimonographs/lgj010.
This paper presents a biologically motivated model of breast cancer development and detection allowing for arbitrary screening schedules and the effects of clinical covariates recorded at the time of diagnosis on posttreatment survival. Biologically meaningful parameters of the model are estimated by the method of maximum likelihood from the data on age and tumor size at detection that resulted from two randomized trials known as the Canadian National Breast Screening Studies. When properly calibrated, the model provides a good description of the U.S. national trends in breast cancer incidence and mortality. The model was validated by predicting some quantitative characteristics obtained from the Surveillance, Epidemiology, and End Results data. In particular, the model provides an excellent prediction of the size-specific age-adjusted incidence of invasive breast cancer as a function of calendar time for 1975-1999. Predictive properties of the model are also illustrated with an application to the dynamics of age-specific incidence and stage-specific age-adjusted incidence over 1975-1999.
本文提出了一个基于生物学的乳腺癌发展与检测模型,该模型考虑了任意筛查计划以及诊断时记录的临床协变量对治疗后生存的影响。通过最大似然法,根据两项名为加拿大国家乳腺筛查研究的随机试验中检测时的年龄和肿瘤大小数据,估计了该模型具有生物学意义的参数。经过适当校准后,该模型很好地描述了美国乳腺癌发病率和死亡率的全国趋势。通过预测从监测、流行病学和最终结果数据中获得的一些定量特征,对该模型进行了验证。特别是,该模型出色地预测了1975 - 1999年期间按日历时间划分的特定大小年龄调整后的浸润性乳腺癌发病率。还通过应用该模型对1975 - 1999年期间特定年龄发病率和特定阶段年龄调整发病率的动态变化进行分析,展示了该模型的预测特性。